Neusoft Medical's Latest Innovation, NeuViz 16 CT Scanner, Approved by FDA for the U.S. Market

SHENYANG, China, July 24 /PRNewswire-Asia/ -- Neusoft Medical Systems Co., Ltd. (Neusoft Medical), a wholly owned subsidiary of Neusoft Corporation (600718.SH), officially announced that its newly developed Computed Tomography(CT) system, NeuViz 16 multi-slice CT scanner, has been approved by the FDA recently, and is also marked as the first of its kind in China. As its first 16 multi-slice CT scanner was shipped to its U.S.-based customers recently, Neusoft Medical has made its newest innovation entered into the global high-end medical market, indicating another breakthrough for the company in the field of high-end medical equipment, following its introduction of PET system in May 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061219/CNTU012LOGO )

NeuViz 16 multi-slice CT scanner is designed with the latest integrated detector for optimized SNR and scanning time, and its patented technology of dynamic focal spot ensures a higher spatial resolution during scanning and creates more detailed 3D/MPR images. The product also features DoseRight Modulation as well as a pediatric protocol to ensure optimized dose without compromising image quality.

One of the core technologies of CT is embedded software, which determines the quality and operating speed of CT imaging, according to Mr. Liu Jian, Vice President of Neusoft Corporation & President of Neusoft Medical. Based on its own accumulated experience and strength in software, Neusoft Medical has always been sticking to the combination strategy of independent development and open innovation. This has enabled the company to successfully develop a series of products, including single-slice, dual-slice, and 16-slice CT scanners. Meanwhile, it has researched and developed a series of computer-aided diagnostic (CAD) software in a variety of specialties to greatly enhance and expand the diagnostic capabilities of CT, which has created a unique competitive advantage for its CT systems. Neusoft Medical's CT products exported to the U.S. market have taken a leading position in the urology and gastrointestinal specialty sector. With the introduction of the NeuViz 16, Neusoft Medical has been recognized as one of the global mid-high-end CT suppliers that can provide a series of CT products at different levels.

About Neusoft Corporation

Neusoft is a leading IT solutions & services company and the largest offshore software & services outsourcing provider in China. Neusoft has set up a large sales and services network in China, as well as subsidiaries in Japan, USA and Europe, maintaining a total of more than 15,000 employees. For more information about Neusoft, please visit http://www.neusoft.com/en .

About Neusoft Medical

Neusoft Medical Systems Co., Ltd. (Neusoft Medical) is a leading medical systems and comprehensive e-hospital solutions provider in China. Founded in 1998, Neusoft Medical has developed its full-scale products of four large-scale medical imaging equipments from the initial CT products to expand in the field of medical IT solutions and medical services. Today Neusoft Medical is the only Chinese medical equipment supplier that can deliver the widest range of diagnostic imaging and other hospital facilities, including PET, CT, MRI, X-ray, Ultrasound, Linear Accelerator, and IT solutions such as UroCARE, MammoCAD, LungCAD, OsteoCare, HIS, RIS and PACS, Patient Monitors, Biochemistry Analyzers and Medical IT Outsourcing.

Neusoft Medical has set up 5 service and spare parts centers respectively in Houston, Lima, Saul Paulo, Dubai, and Shenyang, to provide fast and effective services in the global market, and millions of people in about 60 countries across the world are enjoying Neusoft Medical's products and solutions. For more information about Neusoft Medical, please visit http://medical.neusoft.com/en .

For more information, please contact:

Evelyn Tang

Senior PR Manager

Neusoft Corporation

Tel: +86-24-8366-5663

Email: tangyi@neusoft.com

SOURCE Neusoft Corporation

Back to news